Literature DB >> 25801062

Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria.

Sibel Dosler1, Elif Karaaslan2, A Alev Gerceker1.   

Abstract

In vitro antibacterial and anti-biofilm activities of antimicrobial cationic peptides (AMPs) - melittin and colistin - both alone and in combination with antibiotics were evaluated against clinical isolates of Gram-negative bacteria. Minimum inhibitory concentration (MIC) and fractional inhibitory concentration (FIC) index were determined by the microbroth dilution and chequerboard techniques, respectively. The time-kill curve (TKC) method was used for determining the bactericidal activities of AMPs alone and in combination. Measurements of anti-biofilm activities were performed spectrophotometrically for both inhibition of attachment and 24-hour biofilm formation at MIC or subMIC. According to MIC90 values, the most active agents against Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumoniae were colistin, imipenem and ciprofloxacin, respectively. In combination studies, synergistic effects were mostly seen with colistin-imipenem against E. coli and K. pneumoniae (50 and 54%, respectively), colistin-ciprofloxacin against P. aeruginosa (77%). In TKC studies, synergism was observed with almost all expected combinations, even more frequently than chequerboard method. All of the antimicrobial agents were able to inhibit attachment and 24-hour biofilm formation between 0-57% at 1/10 × MIC and 7-73% at 1 × or 1/10 × MIC, respectively. AMPs seem to be a good candidate for antimicrobial chemotherapy with their antibacterial and anti-biofilm activities as a single agent or in combination with antibiotics.

Entities:  

Keywords:  Antibiotic; Colistin; Gram-negative bacteria; Inhibition of biofilm; Melittin

Mesh:

Substances:

Year:  2016        PMID: 25801062     DOI: 10.1179/1973947815Y.0000000004

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  23 in total

1.  Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.

Authors:  Ali Mohammadi Bardbari; Mohammad Reza Arabestani; Manoochehr Karami; Fariba Keramat; Hossein Aghazadeh; Mohammad Yousef Alikhani; Kamran Pooshang Bagheri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-20       Impact factor: 3.267

2.  Potentiality of Melittin-Loaded Niosomal Vesicles Against Vancomycin-Intermediate Staphylococcus aureus and Staphylococcal Skin Infection.

Authors:  Sirikwan Sangboonruang; Natthawat Semakul; Mohammad A Obeid; Marta Ruano; Kuntida Kitidee; Usanee Anukool; Kidsadagon Pringproa; Panuwan Chantawannakul; Valerie A Ferro; Yingmanee Tragoolpua; Khajornsak Tragoolpua
Journal:  Int J Nanomedicine       Date:  2021-11-16

Review 3.  Applications and evolution of melittin, the quintessential membrane active peptide.

Authors:  Shantanu Guha; Ryan P Ferrie; Jenisha Ghimire; Cristina R Ventura; Eric Wu; Leisheng Sun; Sarah Y Kim; Gregory R Wiedman; Kalina Hristova; Wimley C Wimley
Journal:  Biochem Pharmacol       Date:  2021-09-17       Impact factor: 6.100

4.  Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis.

Authors:  Rasoul Mirzaei; Mohammad Yousef Alikhani; Carla Renata Arciola; Iraj Sedighi; GholamReza Irajian; Elaheh Jamasbi; Rasoul Yousefimashouf; Kamran Pooshang Bagheri
Journal:  Front Microbiol       Date:  2022-06-23       Impact factor: 6.064

5.  Synergism of fused bicyclic 2-aminothiazolyl compounds with polymyxin B against Klebsiella pneumoniae.

Authors:  Rong Wang; Shuang Hou; Xiaojing Dong; Daijie Chen; Lei Shao; Liujia Qian; Zhong Li; Xiaoyong Xu
Journal:  Medchemcomm       Date:  2017-09-14       Impact factor: 3.597

Review 6.  Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review.

Authors:  Alaka Sahoo; Shasank Sekhar Swain; Ayusman Behera; Gunanidhi Sahoo; Pravati Kumari Mahapatra; Sujogya Kumar Panda
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

Review 7.  Adjuvants: friends in vaccine formulations against infectious diseases.

Authors:  G G Guerrero Manriquez; I Tuero
Journal:  Hum Vaccin Immunother       Date:  2021-07-21       Impact factor: 4.526

8.  Prediction of Biofilm Inhibiting Peptides: An In silico Approach.

Authors:  Sudheer Gupta; Ashok K Sharma; Shubham K Jaiswal; Vineet K Sharma
Journal:  Front Microbiol       Date:  2016-06-16       Impact factor: 5.640

9.  Synergistic antibiofilm efficacy of a gallotannin 1,2,6-tri-O-galloyl-β-D-glucopyranose from Terminalia chebula fruit in combination with gentamicin and trimethoprim against multidrug resistant uropathogenic Escherichia coli biofilms.

Authors:  Anwesa Bag; Rabi Ranjan Chattopadhyay
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

10.  In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria.

Authors:  Parvin Askari; Mohammad Hasan Namaei; Kiarash Ghazvini; Mehran Hosseini
Journal:  BMC Pharmacol Toxicol       Date:  2021-07-14       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.